Society of Interventional Radiology Position Statement on the Management of Chronic Iliofemoral Venous Obstruction with Endovascular Placement of Metallic Stents.
Journal
Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
26
05
2023
accepted:
08
06
2023
medline:
23
10
2023
pubmed:
18
6
2023
entrez:
17
6
2023
Statut:
ppublish
Résumé
To state the position of the Society of Interventional Radiology (SIR) on the endovascular management of chronic iliofemoral venous obstruction with metallic stents. A multidisciplinary writing group with expertise in treating venous disease was convened by SIR. A comprehensive literature search was conducted to identify studies on the topic of interest. Recommendations were drafted and graded according to the updated SIR evidence grading system. A modified Delphi technique was used to achieve consensus agreement on the recommendation statements. A total of 41 studies, including randomized trials, systematic reviews and meta-analyses, prospective single-arm studies, and retrospective studies were identified. The expert writing group developed 15 recommendations on the use of endovascular stent placement. SIR considers the use of endovascular stent placement for chronic iliofemoral venous obstruction to be likely to help selected patients, but the risks and benefits have not been fully quantified in well-designed randomized studies. SIR recommends urgent completion of such studies. In the meantime, careful patient selection and optimization of conservative therapy are recommended prior to stent placement, with attention to appropriate stent sizing and quality procedural technique. The use of multiplanar venography with intravascular ultrasound is suggested in diagnosing and characterizing obstructive iliac vein lesions and in guiding stent therapy. After stent placement, SIR recommends close patient follow-up to ensure optimal antithrombotic therapy, durable symptom response, and early identification of adverse events.
Identifiants
pubmed: 37330211
pii: S1051-0443(23)00426-8
doi: 10.1016/j.jvir.2023.06.013
pii:
doi:
Types de publication
Practice Guideline
Research Support, N.I.H., Extramural
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1643-1657.e6Subventions
Organisme : NHLBI NIH HHS
ID : UH3 HL138325
Pays : United States
Informations de copyright
Copyright © 2023 SIR. Published by Elsevier Inc. All rights reserved.